Maxigen Biotech Inc. (1783) Stock Price & Analysis
1783 Stock Chart & Stats
- Day’s Range
- TWD 33.50 - TWD 35.40
- 52-Week Range
- TWD 33.50 - TWD 48.30
- Previous Close
- TWD 35.20
- Volume
- N/A
- Average Volume (3M)
- 63.79K
- Market Cap
- TWD 3.11B
- Enterprise Value
- TWD 2.60B
- Total Cash (Recent Filing)
- TWD 997.26M
- Total Debt (Recent Filing)
- TWD 102.25M
- Price to Earnings (P/E)
- 9.0
- Beta
- 0.31
- Next Earnings
- Mar 17, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 01, 2026
- Dividend Yield
- 5.76%
1783 FAQ
What was Maxigen Biotech Inc.’s price range in the past 12 months?
What is Maxigen Biotech Inc.’s market cap?
When is Maxigen Biotech Inc.’s upcoming earnings report date?
How were Maxigen Biotech Inc.’s earnings last quarter?
Is Maxigen Biotech Inc. overvalued?
Does Maxigen Biotech Inc. pay dividends?
What is Maxigen Biotech Inc.’s EPS estimate?
How many shares outstanding does Maxigen Biotech Inc. have?
What happened to Maxigen Biotech Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Maxigen Biotech Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Maxigen Biotech Inc.
Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development, production, and global commercialization of advanced biomedical and skincare solutions. Its extensive biomedical portfolio includes various orthopedic products such as Formagraft, a bone graft substitute, and Formasetin, a bone void filler. For intra-articular applications in orthopedics, MBI markets injections under the names ArtiAid, ArtiAid Plus, and ArtiBest. The company's offerings also span both orthopedic and dental fields, featuring Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental graft. Specifically for dental use, MBI provides FormaAid, a collagen membrane, and the E-TECH DENTISTAR II sterilizer and disinfectant. Furthermore, HealiAid, a collagen wound dressing product, serves dental and general wound care purposes. MBI also manufactures ophthalmic viscoelastic devices, known as ViscAid, PreviscAid, and BiVisc, and produces Formaderm, a dermal filler injection utilized in plastic surgery. Beyond its medical devices, Maxigen Biotech Inc. offers a comprehensive line of skincare products. This array includes masks for the face, neck, body, and limbs, alongside make-up removers, cleansers, exfoliants, toners, essences, men's grooming items, sunscreens, and specialized body, hand, and foot care formulations. Maxigen Biotech Inc. was established in 1998 and operates from its main office in Taoyuan City, Taiwan.
- Sector
- General
- Industry
- Medical - Instruments & Supplies
- CEO
- Ching-Ting Chen
- Employees
- 127
- Website
- www.mbi-bio.com
- Address
- No. 88, Keji 1st Road, Taoyuan City, TP, 333, TW
Maxigen Biotech Inc. (1783) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |

